PALISADE BIO, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| JOHE KARL | Chief Scientific Officer | Sale | 6,000 | $3.54 | $21,240 | 502,247 | May 1, 2014 |
| GARR RICHARD | CEO | Sale | 7,000 | $4.25 | $29,750 | 240,000 | Apr 22, 2014 |
| OLDAKER WILLIAM CLYDE | — | Tax Withholding | 9,871 | $4.66 | $45,999 | 99,429 | Apr 9, 2014 |
| OGILVIE SCOTT VARDE | — | Tax Withholding | 14,163 | $4.66 | $66,000 | 20,837 | Apr 9, 2014 |
| JOHE KARL | Chief Scientific Officer | Gift | 17,500 | — | — | 508,247 | Apr 3, 2014 |
| JOHE KARL | Chief Scientific Officer | Gift | 17,500 | — | — | 495,747 | Apr 3, 2014 |
| JOHE KARL | Chief Scientific Officer | Sale | 6,000 | $4.11 | $24,660 | 525,747 | Apr 1, 2014 |
| GARR RICHARD | CEO | Gift | 5,000 | — | — | 247,000 | Mar 26, 2014 |
| JOHE KARL | Chief Scientific Officer | Sale | 6,000 | $4.04 | $24,240 | 531,747 | Mar 20, 2014 |
| GARR RICHARD | CEO | Tax Withholding | 140,201 | $3.04 | $426,211 | 1,249,337 | Jan 24, 2014 |
| GARR RICHARD | CEO | Option Exercise | 400,000 | $0.50 | $200,000 | 1,455,327 | Jan 24, 2014 |
| JOHE KARL | Chief Scientific Officer | Gift | 4,000 | — | — | 680,994 | Dec 5, 2013 |
| JOHE KARL | Chief Scientific Officer | Sale | 10,000 | $2.35 | $23,500 | 684,994 | Oct 21, 2013 |
| JOHE KARL | Chief Scientific Officer | Sale | 10,000 | $2.44 | $24,400 | 694,994 | Oct 18, 2013 |
| JOHE KARL | Chief Scientific Officer | Sale | 10,000 | $2.62 | $26,200 | 704,994 | Sep 20, 2013 |
| JOHE KARL | Chief Scientific Officer | Sale | 10,000 | $2.61 | $26,100 | 714,994 | Sep 19, 2013 |
| GARR RICHARD | CEO | Gift | 13,000 | — | — | 1,055,327 | Aug 30, 2013 |
| JOHE KARL | Chief Scientific Officer | Sale | 20,000 | $1.55 | $31,000 | 724,994 | Aug 20, 2013 |
| JOHE KARL | Chief Scientific Officer | Sale | 12,800 | $1.62 | $20,736 | 744,994 | Jul 22, 2013 |
| JOHE KARL | Chief Scientific Officer | Sale | 12,800 | $1.40 | $17,920 | 757,794 | Jun 20, 2013 |
| GARR RICHARD | CEO | Gift | 5,000 | — | — | 202,000 | Jun 7, 2013 |
| JOHE KARL | Chief Scientific Officer | Sale | 12,800 | $1.51 | $19,328 | 770,594 | May 20, 2013 |
| JOHE KARL | Chief Scientific Officer | Sale | 12,800 | $1.13 | $14,464 | 783,394 | Apr 22, 2013 |
| JOHE KARL | Chief Scientific Officer | Sale | 12,800 | $1.14 | $14,592 | 796,194 | Mar 20, 2013 |
| GARR RICHARD | CEO | Sale | 12,000 | $1.15 | $13,800 | 213,000 | Feb 25, 2013 |
| JOHE KARL | Chief Scientific Officer | Sale | 12,800 | $1.18 | $15,104 | 808,994 | Feb 20, 2013 |
| JOHE KARL | Chief Scientific Officer | Sale | 12,800 | $1.27 | $16,256 | 821,794 | Jan 22, 2013 |
| JOHE KARL | Chief Scientific Officer | Sale | 12,800 | $1.16 | $14,848 | 834,594 | Dec 20, 2012 |
| JOHE KARL | Chief Scientific Officer | Sale | 12,800 | $1.00 | $12,800 | 847,394 | Nov 20, 2012 |
| GARR RICHARD | CEO | Gift | 3,000 | — | — | 1,278,327 | Jul 22, 2012 |
| GARR RICHARD | CEO | Gift | 14,000 | — | — | 1,374,148 | Jun 20, 2012 |
| JOHE KARL | Chief Scientific Officer | Other | 256,790 | — | — | 860,194 | Jun 18, 2012 |
| JOHE KARL | Chief Scientific Officer | Other | 745,000 | — | — | 1,126,984 | Nov 14, 2011 |
| GARR RICHARD | CEO | Award / Grant | 19,802 | — | — | 1,588,072 | Jan 28, 2011 |
| CONRON JOHN | Chief Financial Officer | Award / Grant | 18,565 | — | — | 115,492 | Jan 28, 2011 |
| GARR RICHARD | CEO | Award / Grant | 19,802 | — | — | 1,588,072 | Jan 28, 2011 |
| GARR RICHARD | CEO | Gift | 5,000 | — | — | 1,568,270 | Dec 27, 2010 |
| OGILVIE SCOTT VARDE | — | Award / Grant | 15,000 | — | — | 15,000 | Nov 15, 2010 |
| OLDAKER WILLIAM CLYDE | — | Award / Grant | 15,000 | — | — | 104,300 | Nov 15, 2010 |
| JOHE KARL | Chief Scientific Officer | Award / Grant | 143,247 | — | — | 1,871,984 | Nov 11, 2010 |
| GARR RICHARD | CEO | Award / Grant | 138,122 | — | — | 1,628,270 | Nov 11, 2010 |
| CONRON JOHN | Chief Financial Officer | Award / Grant | 34,615 | — | — | 96,927 | Nov 11, 2010 |
| OLDAKER WILLIAM CLYDE | — | Purchase | 7,500 | $2.32 | $17,400 | 86,800 | Sep 16, 2010 |
| CONRON JOHN | Chief Financial Officer | Award / Grant | 10,948 | — | — | 62,312 | Jul 8, 2010 |
| JOHE KARL | Chief Scientific Officer | Award / Grant | 33,253 | — | — | 1,728,737 | Jul 8, 2010 |
| GARR RICHARD | CEO | Award / Grant | 76,953 | — | — | 1,490,148 | Jul 8, 2010 |
| GARR RICHARD | CEO | Purchase | 189,111 | $1.65 | $312,033 | 1,413,195 | Dec 30, 2009 |
| CONRON JOHN | Chief Financial Officer | Purchase | 36,364 | $1.65 | $60,001 | 51,364 | Dec 30, 2009 |
| JOHE KARL | Chief Scientific Officer | Gift | 10,000 | — | — | 1,695,484 | Sep 22, 2009 |
| JOHE KARL | Chief Scientific Officer | Gift | 3,000 | — | — | 1,763,484 | Apr 7, 2009 |